Invention Grant
- Patent Title: C4-carboxylic acid-substituted tryptamine derivatives and methods of using
-
Application No.: US18218216Application Date: 2023-07-05
-
Publication No.: US12077498B2Publication Date: 2024-09-03
- Inventor: Jillian M. Hagel , Ye Cai , Kaveh Matinkhoo , David James Press , Glynnis Elizabeth Jensen , Peter J. Facchini
- Applicant: Enveric Biosciences Canada Inc.
- Applicant Address: CA Calgary
- Assignee: Enveric Biosciences Canada Inc.
- Current Assignee: Enveric Biosciences Canada Inc.
- Current Assignee Address: CA Calgary
- Agency: BERESKIN & PARR LLP/ S.E.N.C.R.L., s.r.l.
- Agent Michael Fenwick
- Main IPC: C07D209/16
- IPC: C07D209/16 ; A61K31/4045 ; A61P25/00 ; C07D209/20 ; C07D401/12 ; C07D403/12 ; C07D405/12
Abstract:
Disclosed are novel C4-carboxylic acid-substituted tryptamine derivative compounds and pharmaceutical and recreational drug formulations containing the same. The pharmaceutical formulations may be used to treat brain neurological disorders.
Public/Granted literature
- US20230357145A1 C4-CARBOXYLIC ACID-SUBSTITUTED TRYPTAMINE DERIVATIVES AND METHODS OF USING Public/Granted day:2023-11-09
Information query
